Literature DB >> 32252591

COVID-19 and the Heart.

Akbarshakh Akhmerov1, Eduardo Marbán1.   

Abstract

Infection with the severe acute respiratory syndrome novel coronavirus produces a clinical syndrome known as 2019 novel coronavirus disease (COVID-19). When severe, COVID-19 is a systemic illness characterized by hyperinflammation, cytokine storm, and elevations of cardiac injury biomarkers. Here, we review what is known about the pathophysiology of COVID-19, its cardiovascular manifestations, and emerging therapeutic prospects. In this rapidly moving field, this review was comprehensive as of April 3, 2020.

Entities:  

Keywords:  biomarkers; cardiovascular diseases; coronavirus; inflammation; myocarditis

Year:  2020        PMID： 32252591      PMCID： PMC7188058          DOI： 10.1161/CIRCRESAHA.120.317055

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


  209 in total

1.  Spontaneous Pneumopericardium and Pneumomediastinum in Twelve COVID-19 Patients.

Authors:  Jorge Paul Juárez-Lloclla; Franco León-Jiménez; Juan Urquiaga-Calderón; Héctor Temoche-Nizama; Mayte Bryce-Alberti; Arianna Portmann-Baracco; Alfonso Bryce-Moncloa
Journal:  Arch Bronconeumol       Date:  2020-10-09       Impact factor: 4.872

2.  Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation.

Authors:  Pierre Miossec
Journal:  Eur J Rheumatol       Date:  2020-05-11

3.  Antiviral effect of amiodarone and its possible role in COVID-19: An appraisal.

Authors:  Snehal Lonare; Mythili Hazarika; Chandra Kr Das
Journal:  Indian J Pharmacol       Date:  2020 Nov-Dec       Impact factor: 1.200

Review 4.  Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices.

Authors:  Matthew A Sparks; Andrew M South; Andrew D Badley; Carissa M Baker-Smith; Daniel Batlle; Biykem Bozkurt; Roberto Cattaneo; Steven D Crowley; Louis J Dell'Italia; Andria L Ford; Kathy Griendling; Susan B Gurley; Scott E Kasner; Joseph A Murray; Karl A Nath; Marc A Pfeffer; Janani Rangaswami; W Robert Taylor; Vesna D Garovic
Journal:  Hypertension       Date:  2020-09-28       Impact factor: 10.190

5.  [Effect of hypertension on outcomes of patients with COVID-19].

Authors:  H U Chengyi; Xiao Lushan; Zhu Hongbo; Zhang Yanpei; Zhang Wenfeng; Liu Li; Zhu Hong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

6.  ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.

Authors:  Thomas H Brannagan; Michaela Auer-Grumbach; John L Berk; Chiara Briani; Vera Bril; Teresa Coelho; Thibaud Damy; Angela Dispenzieri; Brian M Drachman; Nowell Fine; Hanna K Gaggin; Morie Gertz; Julian D Gillmore; Esther Gonzalez; Mazen Hanna; David R Hurwitz; Sami L Khella; Mathew S Maurer; Jose Nativi-Nicolau; Kemi Olugemo; Luis F Quintana; Andrew M Rosen; Hartmut H Schmidt; Jacqueline Shehata; Marcia Waddington-Cruz; Carol Whelan; Frederick L Ruberg
Journal:  Orphanet J Rare Dis       Date:  2021-05-06       Impact factor: 4.123

7.  Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy?

Authors:  Gaia Spinetti; Elisa Avolio; Paolo Madeddu
Journal:  Regen Med       Date:  2021-05-14       Impact factor: 3.806

8.  Regulatory T cell activation, proliferation, and reprogramming induced by extracellular vesicles.

Authors:  Akbarshakh Akhmerov; Russell Rogers; Geoffrey de Couto; Jackelyn Valle; Liang Li; Ahmed Ibrahim; Lizbeth Sanchez; Rui Zhang; Yen-Nien Lin; Weixin Liu; Eduardo Marbán
Journal:  J Heart Lung Transplant       Date:  2021-06-24       Impact factor: 10.247

Review 9.  Mortality rate and biomarker expression within COVID-19 patients who develop acute ischemic stroke: a systematic review and meta-analysis.

Authors:  Ahmed Yassin; Ansam Ghzawi; Abdel-Hameed Al-Mistarehi; Khalid El-Salem; Amira Y Benmelouka; Ahmed M Sherif; Nesrine BenhadjDahman; Nameer AlAdamat; Amine Jemel; Ahmed Negida; Mohamed Abdelmonem
Journal:  Future Sci OA       Date:  2021-05-11

10.  Alteration of Autonomic Nervous System Is Associated With Severity and Outcomes in Patients With COVID-19.

Authors:  Yuchen Pan; Zhiyao Yu; Yuan Yuan; Jiapeng Han; Zhuo Wang; Hui Chen; Songyun Wang; Zhen Wang; Huihui Hu; Liping Zhou; Yanqiu Lai; Zhen Zhou; Yuhong Wang; Guannan Meng; Lilei Yu; Hong Jiang
Journal:  Front Physiol       Date:  2021-05-19       Impact factor: 4.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.